Ziraoui NE, Salazar M, Kensington A. BCLC™ NAD⁺ Supplement System Targeting SIRT1: A Time-Sequential Biphasic NMN-Resveratrol-Quercetin Formulation with Supporting Clinical and Pharmacological Evidence. IJPHMR. 2026;6(4):36-44. doi:10.62051/ijphmr.v6n4.06